Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
iSpecimen Inc - SIC # 7372 - PREPACKAGED SOFTWARE
Ticker
Exchange
SIC #
Website
Latest Ticker
ISPC
Nasdaq
7372
https://www.ispecimen.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for iSpecimen Inc
iSpecimen Inc. (NASDAQ:ISPC) Q4 2023 Earnings Call Transcript
- Mar 15th, 2024 2:48 pm
iSpecimen Full Year 2023 Earnings: Misses Expectations
- Mar 15th, 2024 11:11 am
iSpecimen Reports Full Year 2023 Results
- Mar 14th, 2024 12:00 pm
iSpecimen Reschedules Full Year 2023 Earnings Release and Conference Call
- Mar 12th, 2024 11:07 pm
iSpecimen to Report Full Year 2023 Financial Results on March 13, 2024
- Mar 5th, 2024 9:30 pm
iSpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based Research
- Jan 23rd, 2024 12:30 pm
Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET
- Jan 22nd, 2024 9:15 pm
iSpecimen to Participate in Maxim Group Healthcare IT Virtual Conference, January 24 & 25, 2024
- Jan 18th, 2024 1:11 pm
iSpecimen Strengthens Global Oncology Biospecimen Offering
- Dec 7th, 2023 12:30 pm
iSpecimen Inc. (NASDAQ:ISPC) Q3 2023 Earnings Call Transcript
- Nov 5th, 2023 4:01 pm
iSpecimen Reports Third Quarter 2023 Financial and Operating Results
- Nov 2nd, 2023 11:30 am
iSpecimen Expands Proprietary Provider Network to Help Advance Infectious Disease Research
- Oct 26th, 2023 11:30 am
iSpecimen Preannounces Third Quarter 2023 Revenue Increase of 60-70% Sequentially
- Oct 23rd, 2023 11:30 am
iSpecimen Launches Next-Day Quote Service for Medical Researchers and Biospecimen Providers
- Sep 28th, 2023 11:30 am
Insider Buying: Benjamin Bielak Acquires 18,000 Shares of iSpecimen Inc
- Sep 16th, 2023 5:01 am
iSpecimen Expands Provider Network to Enhance Support for Women’s Health Research
- Sep 13th, 2023 11:30 am
iSpecimen Announces Organizational Changes to Enhance Operational Efficiencies and Drive Profitability
- Sep 6th, 2023 8:05 pm
iSpecimen Launches New Virtual Cancer Sequencing Procurement Program
- Aug 30th, 2023 11:30 am
iSpecimen Enhances Proprietary Marketplace Platform to Streamline Biospecimen Matchmaking for Researchers and Providers
- Aug 16th, 2023 11:30 am
iSpecimen Introduces New Marketplace Functionality to Streamline Access to Clinical Remnant Samples for Researchers
- Aug 9th, 2023 11:30 am
Scroll